Alkermes plc (ALKS) vs Amneal Pharmaceuticals, Inc. (AMRX)
A side-by-side comparison of Alkermes plc and Amneal Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALKS
Alkermes plc
$41.90HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
AMRX
Amneal Pharmaceuticals, Inc.
$20.37HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — ALKS vs AMRX
growth of $100 · dividends reinvested · last 10yALKS -7.3% (-0.8%/yr)AMRX -13.6% (-1.5%/yr)ALKS compounded faster over this window
ALKS AMRX
ALKS vs AMRX: by the numbers
- •ALKS is the larger company ($7.03B vs $6.50B market cap).
- •AMRX trades at the lower trailing earnings multiple (41.78 vs 109.39 P/E), one valuation lens rather than an overall verdict.
- •AMRX converts more revenue to profit (5.05% vs 3.97% net margin).
Metrics side by side
Valuation
| Metric | ALKS | AMRX |
|---|---|---|
| P/E ratio | 109.39 | 41.78 |
| Forward P/E | N/A | 19.90 |
| P/S ratio | 4.21 | 2.09 |
| P/B ratio | 3.89 | 196.97 |
| EV / EBITDA | 45.21 | 15.34 |
| FCF yield | 3.15% | 1.28% |
Profitability
| Metric | ALKS | AMRX |
|---|---|---|
| Gross margin | 84.56% | 39.32% |
| Operating margin | 17.21% | 12.93% |
| Net margin | 3.97% | 5.05% |
| ROE | 3.66% | 476.51% |
| ROIC | 2.12% | 13.45% |
Growth (annualized)
| Metric | ALKS | AMRX |
|---|---|---|
| Revenue CAGR (5Y) | 8.68% | 8.67% |
| EPS CAGR (5Y) | N/A | -17.72% |
| FCF CAGR (5Y) | 20.00% | -14.46% |
| Total return CAGR (5Y) | 6.73% | 30.25% |
Frequently asked
- Which has the lower trailing P/E, ALKS or AMRX?
- AMRX has the lower trailing P/E: ALKS trades at 109.39 and AMRX at 41.78. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is ALKS or AMRX more profitable?
- AMRX runs the higher net margin — ALKS at 3.97% versus AMRX at 5.05%.
- How have ALKS and AMRX total returns compared?
- Over the past 10 years, ALKS delivered -0.82% and AMRX delivered -1.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alkermes P/E ratioAmneal Pharmaceuticals P/E ratioAlkermes ROEAmneal Pharmaceuticals ROEAlkermes operating marginAmneal Pharmaceuticals operating marginAlkermes revenue growthAmneal Pharmaceuticals revenue growthAlkermes free cash flowAmneal Pharmaceuticals free cash flow
Alkermes & Amneal Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.